DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Shaw AT, Mehra R, Kim DW et al.
Clinical activity of the ALK inhibitor LDK378 in advanced, ALK-positive NSCLC.
J Clin Oncol 2013;
31 (Suppl. 01) Abstr 8010
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.